Carasent AB (publ)APXZF 80 Gross Margin % is 84.58% as of Mar. 2026, which is 3% above its 10-year median of 81.75. GuruFocus rates APXZF with a GF Score™ of 80/100 and a GF Value™ of $0.18. The stock has 3 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Carasent AB (publ) ranks better than 89.67% on this metric.
The historical rank and industry rank for Carasent AB (publ)'s Gross Margin % or its related term are showing as below:
APXZF'
s Gross Margin % Range Over the Past 10 Years
Min: 63.3 Med: 81.75 Max: 84.54
Current: 84.09
During the past 13 years, the highestGross Margin % of Carasent AB (publ) was 84.54%. The lowest was 63.30%. And the median was 81.75%.
APXZF's Gross Margin % is ranked better than 89.67% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs APXZF: 84.09
Carasent AB (publ) had a gross margin of 84.58% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Carasent AB (publ) was 0.80% per year.
Carasent AB (publ) (OTCPK:APXZF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Carasent AB (publ) had a gross margin of 84.58% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Carasent AB (publ) Gross Margin % Related Terms
Carasent AB (publ) Gross Margin % Historical Data
* Premium members only.
The historical data trend for Carasent AB (publ)'s Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
APXZF vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, Carasent AB (publ)'s Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carasent AB (publ) Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s Gross Margin % distribution charts can be found below:
* The bar in red indicates where Carasent AB (publ)'s Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Carasent AB (publ) (APXZF) has a Gross Margin % of 84.58% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Carasent AB (publ) and its competitors. This is near median its historical median of 81.75. Over the past decade, Carasent AB (publ)'s Gross Margin % has ranged from 63.30 to 84.54. According to the industry distribution chart, Carasent AB (publ) ranks #65 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is Carasent AB (publ)'s Gross Margin % too high?
Carasent AB (publ)'s current Gross Margin % of 84.58% is near median its 10-year median of 81.75. Over the past 10 years, this metric has ranged from a low of 63.30 to a high of 84.54. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Carasent AB (publ)'s value of 84.58% is 111% above this industry median. Based on the distribution chart, Carasent AB (publ) ranks #65 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Carasent AB (publ) has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Carasent AB (publ)'s Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Carasent AB (publ) ranks #65 out of 629 companies for Gross Margin %. This places Carasent AB (publ) in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Carasent AB (publ)'s value of 84.58% is 111% above this benchmark. Historically, Carasent AB (publ)'s own Gross Margin % has ranged from 63.30 to 84.54 over the past decade. While the company's 10-year median is 81.75 vs. the industry median of 40.09, Carasent AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carasent AB (publ)'s current Gross Margin % of 84.58% is 111% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Carasent AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carasent AB (publ)'s current Gross Margin % is 84.58%, which is near median its own 10-year median of 81.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carasent AB (publ) stock overvalued right now?
Carasent AB (publ) (APXZF) has a current Gross Margin % of 84.58%. The stock's GF Value™ is $0.18, compared to a current price of $0.15 — trading 16.7% below its estimated fair value. The current Gross Margin % is 84.58%, which is near median its 10-year median of 81.75 and 111% above the Healthcare Providers & Services industry median of 40.09. Carasent AB (publ)'s overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Carasent AB (publ) (APXZF), the current Gross Margin % is 84.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carasent AB (publ) (APXZF) Overvalued in 2026?
Based on GuruFocus' analysis, Carasent AB (publ) stock appears to be undervalued.
The current stock price of $0.15 is trading 16.7% below its estimated GF Value™ of $0.18.
Key valuation signals for APXZF:
Gross Margin %: 84.58% (near median its 10-year median of 81.75)
GF Value™: $0.18 vs. price of $0.15 (16.7% below fair value)
Industry Position: 111% above the Healthcare Providers & Services median (#65 of 629)
No single metric tells the full story. See the APXZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
80GF Score
Get the complete analysis for APXZF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APXZF has been successfully added to your 
